NeuPath Health Inkomsten in het verleden
Verleden criteriumcontroles 0/6
NeuPath Health has been growing earnings at an average annual rate of 37.1%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 5.9% per year.
Belangrijke informatie
37.1%
Groei van de winst
62.8%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | -6.7% |
| Inkomstengroei | 5.9% |
| Rendement op eigen vermogen | 0.03% |
| Nettomarge | -0.1% |
| Volgende winstupdate | 14 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel
Aug 18
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively
Jun 16The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues
Aug 19Opbrengsten en kosten
Hoe NeuPath Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 69 | 0 | 10 | 0 |
| 31 Mar 24 | 68 | 0 | 9 | 0 |
| 31 Dec 23 | 66 | 0 | 9 | 0 |
| 30 Sep 23 | 65 | -2 | 9 | 0 |
| 30 Jun 23 | 65 | -3 | 9 | 0 |
| 31 Mar 23 | 63 | -3 | 9 | 0 |
| 31 Dec 22 | 63 | -4 | 9 | 0 |
| 30 Sep 22 | 62 | -3 | 10 | 0 |
| 30 Jun 22 | 62 | -3 | 10 | 0 |
| 31 Mar 22 | 62 | -3 | 10 | 0 |
| 31 Dec 21 | 61 | -3 | 10 | 0 |
| 30 Sep 21 | 58 | -3 | 10 | 0 |
| 30 Jun 21 | 55 | -3 | 9 | 0 |
| 31 Mar 21 | 50 | -5 | 9 | 0 |
| 31 Dec 20 | 48 | -5 | 8 | 0 |
| 30 Sep 20 | 48 | -7 | 8 | 0 |
| 30 Jun 20 | 49 | -8 | 8 | 0 |
| 31 Mar 20 | 50 | -5 | 8 | 0 |
| 31 Dec 19 | 50 | -5 | 8 | 0 |
| 31 Dec 18 | 40 | -5 | 8 | 0 |
| 31 Dec 17 | 20 | -4 | 6 | 0 |
Kwaliteitswinsten: NPTH is currently unprofitable.
Groeiende winstmarge: NPTH is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: NPTH is unprofitable, but has reduced losses over the past 5 years at a rate of 37.1% per year.
Versnelling van de groei: Unable to compare NPTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: NPTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement op eigen vermogen
Hoge ROE: NPTH has a negative Return on Equity (0.027%), as it is currently unprofitable.